Cefazolin for Injection: Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.
Brand(s)
Last updated
Summary
Product
CEFAZOLIN FOR INJECTION, USP
Issue
Health products - Labelling
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| FRESENIUS KABI CANADA LTD | Cefazolin for Injection,USP | DIN 02401029 | Powder for Solution | 100 G / BAG | 40228 00125, 40228 00135 |
Issue
Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto, ON M9W 0C8
Published by
Health Canada
Audience
General public
Health professionals
Industry
Distribution
National
Recall class
Type III
Identification number
RA-81589
Get notified
Receive emails about new and updated recall and safety alerts.